NCBiotech News

Durham-based Tergus Pharma expects to add 200 workers over the next five years after it converts a newly acquired 100,000-square-foot building into a new headquarters and commercial manufacturing facility. 

By Barry Teater, NCBiotech Writer

North Carolina State University (NCSU) will lead a new $30 million research program intended to make crops more resilient against environmental stresses while reducing the need for chemical treatments and irrigation.

NCSU will receive about $8 million of the program’s funding over six years to study how microbes in soil, roots and leaves interact with plants and affect plant health and productivity.

Durham immunotherapy company Dualogics has entered into a collaboration agreement with South Korea's Y-Biologics to use their combined expertise to discover and develop novel cancer antibodies.

When Chiesi USA moved into its new 55,000-square-foot headquarters in Cary earlier this year, executives of the specialty pharmaceutical company made sure there was extra space for long-term growth.

Durham's Bioventus is teaming with MTF Biologics, the largest tissue bank in the world, to develop newborns' placental tissue for knee injections to treat osteoarthritis.

A $200,000 NCBiotech grant to a UNC research lab in 2016 has led to new understanding of how the brain drives binge eating.

David King, LabCorp’s long-time chairman, president and CEO, will retire Oct. 31 and be succeeded the next day by Adam Schechter, a former Merck executive.

KriGen Pharmaceuticals, a young India-based pharmaceutical company, is investing $7 million and hiring 100 employees at its new manufacturing facility and quality control lab in the Harnett County community of Lillington, about 30 miles south of Raleigh.

Xona Microfluidics, a unique cell-culture systems company with an R&D lab in Durham, is ramping up operations with two new products used by neuroscientists to study diseases such as Alzheimer’s and epilepsy.

Worldwide Clinical Trials, a Morrisville clinical research organization with operations in 60 countries, is meeting fast-changing needs in oncology and rare disease clinical trials.

Parexel International Corp., a global contract research organization headquartered near Boston, agreed today to add 264 employees to its Durham operations and turn the site into a shared headquarters by adding some key functions to the North Carolina campus.

This year’s BIO International Convention in Philadelphia will have a distinctive North Carolina flair, with two panel discussions assembled by the North Carolina Biotechnology Center and a presentation highlighting North Carolina as a global innovation hub.

Newly spawned IQVIA MedTech says it will leverage several practice areas from its growing Research Triangle operations.

As part of its plans to use only renewable electricity in the U.S., Novo Nordisk is investing $70 million in a 672-acre solar panel installation in southeastern North Carolina’s Pender County.

Cook Medical, a medical device company with major operations in Winston-Salem, will distribute a disposable duodenoscope from Danish developer Ambu in the U.S. after FDA approval.